Avidity Biosciences, Inc. (RNA)

Avidity Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,973	3,470	671	1,474	1,115	958
Market Cap Growth	175.86%	417.36%	-54.52%	32.27%	16.40%	-
Enterprise Value	9,155	1,889	139	1,080	703	617
Last Close Price	72.86	29.08	9.05	22.19	23.77	25.52
PS Ratio	526.22	318.39	70.15	159.85	119.53	141.10
PB Ratio	5.67	2.44	1.34	2.55	2.92	3.13
P/TBV Ratio	5.82	2.44	1.34	2.55	2.92	3.13
EV/Sales Ratio	438.73	173.31	14.50	117.11	75.35	90.94
Debt / Equity Ratio	0.03	0.01	0.02	0.02	0.03	0.00
Net Debt / Equity Ratio	-0.97	-1.05	-1.17	-1.04	-1.03	-1.07
Net Debt / EBITDA Ratio	3.00	3.97	2.51	3.38	3.35	7.45
Net Debt / FCF Ratio	3.08	4.85	4.75	4.31	4.00	8.56
Asset Turnover	0.01	0.01	0.02	0.02	0.02	0.03
Quick Ratio	11.13	15.61	7.49	11.84	13.70	22.58
Current Ratio	11.57	15.74	7.58	12.00	13.86	22.74
Return on Equity (ROE)	-32.44%	-33.47%	-39.34%	-36.27%	-34.32%	-23.62%
Return on Assets (ROA)	-20.28%	-21.60%	-23.24%	-20.97%	-19.38%	-12.85%
Return on Capital Employed (ROCE)	-31.20%	-25.90%	-43.00%	-30.50%	-29.70%	-13.90%
Earnings Yield	-5.01%	-9.29%	-31.65%	-11.80%	-10.59%	-4.63%
FCF Yield	-5.39%	-8.88%	-18.39%	-9.43%	-8.84%	-3.99%
Buyback Yield / Dilution	-33.44%	-52.83%	-39.97%	-25.91%	-91.24%	-698.49%

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q